[111In]PSMA-I&T: expanding the spectrum of PSMA-I&T applications towards SPECT and radioguided surgery

Prostate-specific Membrane Antigen–radioguided Surgery for Metastatic Lymph Nodes in Prostate Cancer

(2015) Tobias Maurer et al.   EUROPEAN UROLOGY

Evaluation of Hybrid 68Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy

(2015) M. Eiber et al.   JOURNAL OF NUCLEAR MEDICINE

68Ga- and 177Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies

(2015) M. Weineisen et al.   JOURNAL OF NUCLEAR MEDICINE

Synthesis and preclinical evaluation of DOTAGA-conjugated PSMA ligands for functional imaging and endoradiotherapy of prostate cancer

(2014) Martina Weineisen et al.   EJNMMI Research

68Ga-Complex Lipophilicity and the Targeting Property of a Urea-Based PSMA Inhibitor for PET Imaging

(2012) Matthias Eder et al.   BIOCONJUGATE CHEMISTRY

DOTAGA-Anhydride: A Valuable Building Block for the Preparation of DOTA-Like Chelating Agents

(2012) Claire Bernhard et al.   CHEMISTRY-A EUROPEAN JOURNAL

68Ga-Labeled Inhibitors of Prostate-Specific Membrane Antigen (PSMA) for Imaging Prostate Cancer

(2010) Sangeeta Ray Banerjee et al.   JOURNAL OF MEDICINAL CHEMISTRY